Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 24 Late-Breaking Discussion: The FLOW Trial
Author(s): Harriette Van Spall , Added: 1 year ago
AHA Conference 2024 — Semaglutide shows increased benefits in CKD patients based on their cardiovascular status and risk profile.Dr Harriette Van Spall (McMaster University, CA) sits down with Dr Katherine Tuttle (University of Washington, US) to discuss the effects of semaglutide in patients with chronic kidney disease (CKD).The FLOW trial (NCT03819153) is designed to assess the effect of… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
ADA 2025 Late-Breaking Science Collection
Author(s): Sue Pedersen Added: 9 months ago
Watch Expert Interviews sharing the late-breaking trial data from the American Diabetes Association's Scientific Sessions 2025. View more

Cardiovascular Kidney Metabolic
Integrating New Weight Management Therapies into Comprehensive CVD Care
Author(s): Steven E Nissen Added: 1 year ago
Is BMI the best indicator to identify CVD patients who can be treated with GLP-1 RAs and other weight management therapies?In this short interview, Dr Steven Nissen (Cleveland Clinic, Cleveland, US) discusses how to determine which CVD patients will benefit most from treatment with GLP-1 RAs. He highlights how lifestyle changes are often ineffective in achieving weight loss goals, and therefore,… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
The Role of GLP-1 in Heart Failure
Author(s): Amina Rakisheva , Anton Zatsarinnyy Added: 2 months ago

Inherited and Congenital Cardiac Conditions

Heart Failure
William Herrington
Research Area(s) / Expertise: Job title: Professor of Trials and Epidemiology of Kidney Disease
Professor William Herrington is an Honorary Consultant Nephrologist at Oxford Kidney Unit and the Professor of Trials and Epidemiology of Kidney Disease at the Nuffield Department of Population Health, University of Oxford.Prof Herrington earned his MD from the University of Cambridge in 2013, focusing on the impact of lowering LDL cholesterol on stroke in chronic kidney disease.He has previously… View more
Omron logo
Omron Healthcare is a manufacturer of medical equipment for therapy and health monitoring. Our range of products includes blood pressure monitors, portable ECG, augmentation index device, respiratory therapy devices, electronic fever thermometers and body fat monitors among others. Our eco-friendly products are not only known for their high quality and performance standards, but also for their… View more
Research Area(s) / Expertise: Job title: Professor
Tina Vilsbøllis a Clinical Professor and Head of Clinic at Steno Diabetes Center, Copenhagen, Denmark. She has been involved in diabetes research since 1997 and in 2004 she established the Center for Diabetes Research at Gentofte Hospital, University of Copenhagen, Denmark, now part of Steno Diabetes Centre Copenhagen. Her research is focused on the pathophysiology of obesity, prediabetes,… View more
Bariatric Surgery: Reduced CVD Risk via PREVENT Equations
Author(s): Danxia Yu Added: 1 year ago
Outcomes from a new CV disease risk assessment tool show significant improvements in CV, kidney and metabolic health after bariatric surgery. The study also found a reduction in estimated 10 year risk of developing total CV disease and a reduction in the risk of developing heart failure one year after bariatric surgery.In this short interview, Dr Danxia Yu (Vanderbilt University Medical Center,… View more

Cardiovascular Kidney Metabolic

Prevention & Chronic Conditions
AHA EPI | Lifestyle 2026
Start date: Mar 17, 2026 End date: Mar 20, 2026
EPI|Lifestyle 2026 is the American Heart Association’s scientific meeting focused on epidemiology, prevention, lifestyle and cardiometabolic health, held from 17–20 March 2026 at the Sheraton Boston, Boston, Massachusetts, USA. The conference brings together population scientists, clinicians and public health professionals to discuss translational and population science, cardiovascular disease … View more

Cardiovascular Kidney Metabolic

Prevention & Chronic Conditions
Simplifying Guidelines in Cardio-Kidney-Metabolic Disease
Author(s): Faiez Zannad Added: 1 year ago
Although cardio-kidney-metabolic disease (CKMD) incorporates conditions which share common risk factors, guidelines are often complex and vary between specialist groups. How can we achieve simpler CKMD guidelines to improve implementation?In this short interview, Dr Faiez Zannad (University of Lorraine, Nancy, FR) advocates for a single-set of overarching CKMD guidelines across all specialties… View more

Cardiovascular Kidney Metabolic